FDA Inspection 620063 — Carter BloodCare

Carter BloodCare — FEI 3003830999

The FDA completed an inspection of Carter BloodCare on October 15, 2009 in Woodway, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 15, 2009
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Woodway, TX (United States)

Citations

IDCFRDescription
442521 CFR 606.60(a)Equipment observed, standardized, calibrated